Search Results

Site Search

search - Mayo Clinic Laboratories

Search Results Site Search...

NY State Informed Consent Tests - Mayo Clinic Laboratories

NY State Informed Consent Tests New York State clients are required by New York State regulations to have completed informed-consent forms on file. When ordering the following tests, all NYS clients are required to indicate to...

Nicotine - Insights

Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.

Hot Topic Archives - Page 5 of 7 - Insights

Skip to Content MayoACCESS MayoLINK...

New tests launched in March - Insights

In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Autoimmune Movement Disorders - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.

autoimmune-paraneoplastic-gastrointestinal-dysmotility-evaluation-algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Gastrointestinal Dysmotility Evaluation Algorithm ■ PCA-2 IFA titer■ ANNA-1 antibody by immunoblot ■ ANNA-2 antibody...

autoimmune-paraneoplastic-dysautonomia-evaluation-algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Autoimmune/Paraneoplastic Dysautonomia Evaluation Algorithm 05/2024 ■ AP3B2 antibody by CBA ■ AP3B2 antibody by IF titer assay ■ PCA-2 IFA titer■ ANNA-1...

It Remains Unknown: Link between Gadolinium Exposure via MRI Exams and Health Effects in Patients with Normal Renal Function - Insights

There have been concerns in the U.S. recently about the possible harmful side effects from absorbing gadolinium-based contrast agents into the body during some MRI exams. To address some of the anxiety and concerns over this issue, Paul...

IgA-mediated autoimmune bullous dermatoses - Insights

In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss autoimmune bullous dermatoses, the rare category of blistering skin diseases that are caused by the development of autoantibodies against various constitutive parts of the...